road map: getting a cancer study done at jefferson sylvia o’neill, md associate director of...
TRANSCRIPT
ROAD MAP: Getting a Cancer Study Done at JeffersonSylvia O’Neill, MDAssociate Director of Regulatory Affairs and Quality AssuranceClinical Trials Office
NCI Guidelines AKA: the CORE Grant
• As an NCI Designated Cancer Center we are mandated to follow the current NCI guidelines.
• All cancer trials enrollment need to be registered• All status changes are done through Alex Lebrun
Org chart
The submission process
MDG
PRC
IRB
PRC and IRB Simultaneous
Amendments
New trial
Multi-disciplinary Groups
• GI• Aero-Digestive• Hematologic• Women’s Cancer• GU• Melanoma and Cutaneous Malignacies• Solid Tumors
Protocol Review Committee (fka: CCRRC)
comprises investigators broadly representing basic and clinical sciences that:
• Reviews scientific integrity of cancer clinical trials• Meetings occur the second and fourth Monday of the month• Deadlines are two weeks prior to the meeting• Reviewers are not confidential and there is open communication• Cancer trials are not reviewed by IRB without written PRC
approval • IRB copied on correspondence from PRC to PIs regarding trial
closure for compliance or accrual • Assures protocol compliance by monitoring accrual
Protocol Review Committee Approval Format:
• Approved
• Approved with administrative changes• Changes must be made but do not need to come back to PRC
• Approval with the following recommendations --- optional
• The PRC will sign off on protocols with no further review and the IRB will be made aware of the recommendations.
• Changes are not required and do not need to come back to PRC
• Conditional approval with mandatory stipulation changes
• The PRC final approval letter will not be sent to the PI until the issues raised here are completed satisfactorily • Changes come back to the Administrative Chair for verification of change but do not go back to the full
board for approval
• Disapproved- revisions needed• Disapproved
PRC Amendment review
When must an amendment get PRC approval?
The amendment changes at least one of the following: a. Inclusion/exclusion criteria
b. Objectives
c. Statistics
d. Subject population
How do amendments get submitted to PRC? Send an email to: [email protected] and attach the following documents:
1. MCSF with tracked changes 2. Summary of changes 3. Tracked
Closure Policy
• Per NCI Guidelines we must close trials that are not or have low accruals.
• Zero accrual at 6 months after activation
• Have less than 15% after 6 months of activation
• Have less than 30 % after one year of activation
We are allowed to suspend the clock on a trial, please notify us at [email protected]
Data Safety Monitoring Committee
• Policy established in collaboration with the NCI in 2011• Meets quarterly • Currently oversees 42 IIT clinical trials • The DSMC coordinator assigns a Medical Monitor – recommends
continuation, suspension, or termination • May call for an adhoc meeting to discuss action plans • Assign a category of risk to every IIT
In a nutshell…..
Call our Clinical Trials Office (fka CRMO) 215-955-1661
Email the PRC at : PRC @Jefferson.edu